MRNA
'Ticker: MRNA
Direction: Up
Prognosis: Buy Calls (Author bought $40 and $41 calls expiring this week, considering rolling to later dates)
Reasoning: New Covid-like virus discovered, rising avian flu concerns, large institutional buying, bullish technical indicators (RSI divergence, MACD turning up), high call option volume and open interest. Author acknowledges that a drop below $30 could invalidate the thesis.
Disclaimer: This is not financial advice. MRNA is volatile; know your risk tolerance.
Bonus: Author also mentions potential plays on HD puts, LOW puts, and CLF calls.'
Direction: Up
Prognosis: Buy Calls (Author bought $40 and $41 calls expiring this week, considering rolling to later dates)
Reasoning: New Covid-like virus discovered, rising avian flu concerns, large institutional buying, bullish technical indicators (RSI divergence, MACD turning up), high call option volume and open interest. Author acknowledges that a drop below $30 could invalidate the thesis.
Disclaimer: This is not financial advice. MRNA is volatile; know your risk tolerance.
Bonus: Author also mentions potential plays on HD puts, LOW puts, and CLF calls.'
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.